Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin-impregnated uterine gauze for postpartum bleeding after cesarean section
IRCT20160825029520N3Phase 3Completed
- Sponsor
- Neyshabour University of Medical Sciences
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of oxytocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Neyshabour University of Medical Sciences. Primary endpoints: Amount of bleeding, Physiological parameters and 1 more. Started May 2021; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20160825029520N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160825029520N3.